pocketful logo
Remus Pharmaceuticals Ltd logo

Remus Pharmaceuticals Ltd

NSE: REMUS BSE: 78788

₹746.90

(4.40%)

Wed, 13 May 2026, 10:34 pm

Remus Pharmaceuticals Share Price Live Chart

1 Day

(4.40%)

No Result Found

Summary

  • Market Cap

    864.36

  • Net Profit

    38.42

  • P/B

    5.15

  • Sector P/E

    34.42

  • P/E

    45.37

  • EV/EBITDA

    26.32

  • Debt/Equity (Industry)

    0.29

  • Interest Cover (Industry)

    4.50

  • ROCE (Industry)

    9.39

  • RONW (Industry)

    7.26

  • ROE

    18.58

  • ROCE

    21.60

  • Debt/Equity

    0.09

  • EPS (TTM)

    24.53

  • Dividend Yield

    0.10

  • Book Value

    217.13

  • Interest Cover

    33.42

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026SEPT 2025MAR 2025SEPT 2024JUN 2024
Promoters70.9570.9170.8570.8470.66
FII5.285.024.773.163.00
DII0.830000
Public22.9324.0824.3726.0026.34
Government00000

Read More

Technical Analysis

RSI

57.58

MACD

26.28

50 DMA

655.97

200 DMA

738.68

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic885.10775.10730.20665.10620.20555.10445.10
Fibonacci775.10733.08707.12665.10623.08597.12555.10
Camarilla715.55705.47695.38665.10675.22665.13655.05

Pivots Level: Classic

R3

+220

885.10

R2

+110

775.10

R1

+65.10

730.20

665.10
665.10
Pivot Point
LTP: 722.20

S1

-44.90

620.20

S2

-110

555.10

S3

-220

445.10

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    720.53

  • 20-EMA

    697.14

  • 30-EMA

    684.54

  • 50-EMA

    675.82

  • 100-EMA

    687.83

  • 200-EMA

    745.54

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
10 Nov 2025dividend₹0.50 Dividend /Share14 Nov 2025
10 Nov 2025board-meetingsHalf Yearly Results, Interim Dividend
02 Sept 2025agm
30 Jun 2025bonus1:1 Bonus Issue of Equity Shares04 Jul 2025
17 May 2025dividend₹0.50 Dividend /Share18 Sept 2025
09 Nov 2024dividend₹1.00 Dividend /Share20 Nov 2024
29 Aug 2024agm
04 Jun 2024bonus3:1 Bonus Issue of Equity Shares06 Jun 2024
23 Apr 2024dividend₹4.00 Dividend /Share02 May 2024
23 Apr 2024egm

Read More

Peer Comparison

Remus Pharmaceuticals Ltd logo

Remus Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Remus Pharmaceuticals Ltd About

Remus Pharmaceuticals is engaged in marketing and distribution of pharmaceuticals products and allied products.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2015

Headquarters

CEO

SWAPNIL JATINBHAI SHAH

Employees

Contact

Website icon

Website

https://www.remuspharma.com

Email icon

Email

cs@remuspharma.com

Phone icon

Phone

91-079-29999857

Location icon

Location

1101 to 1103 South Tower One42, B/H Ashok Vatika Amblibopal Rd, Ahmedabad, Gujarat, 380054

Read More

Remus Pharmaceuticals Ltd Company History

YearHistory
2015
  • The Company was incorporated as a private limited company under the name Remus Pharmaceuticals Private Ltd.
  • The Company initiated finished formulation exports and marketing.
2019
  • The Company collaborated and partnered with multinational pharmaceuticals.
2022
  • The Company initiated strategic presence in a few key markets.
2023
  • The Company was converted from a private limited company to a public limited company.
  • The name of the Company was changed to Remus Pharmaceuticals Limited.
  • A fresh certificate of incorporation was issued to the Company.
2024
  • The Company issued Bonus Shares in the Ratio of 3:1.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
CHHATTISGARH INVESTMENTS LIMITEDbulkSell80003599.0326 Jul 2023
JINENDRA GbulkBuy75002387.9215 Jun 2023
INDIA EMERGING GIANTS FUND LIMITEDbulkBuy157002079.2301 Jun 2023
YUGA STOCKS AND COMMODITIES PRIVATE LIMITED .bulkSell106002079.901 Jun 2023
MONEYWISE FINANCIAL SERVICES PRIVATE LTDbulkSell107001712.8529 May 2023
NEGEN CAPITAL SERVICES PRIVATE LIMITEDbulkBuy340001793.929 May 2023
JAIN SANJAY POPATLALbulkBuy100001711.2529 May 2023
GPRAKASHCHAND BAID HUFbulkBuy80001711.2529 May 2023

Read More

Remus Pharmaceuticals Ltd News

Remus Pharmaceuticals Reports 34% Jump in H1 Net Profit to 175M Rupees

Remus Pharmaceuticals reported H1 consolidated net profit of 175 million rupees compared to 131 million rupees in the same period last year. Revenue increased to 4 billion rupees from 2.72 billion rupees year-over-year. EBITDA rose to 269 million rupees from 211 million rupees, though EBITDA margin declined to 6.7% from 7.8% in the previous year.

10 Nov 2025

earnings

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800